Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A controlled trial of Casodex (bicalutamide) vs. flutamide, each in combination with luteinising hormone-releasing hormone analogue therapy in patients with advanced prostate cancer. Casodex Combination Study Group.
Soloway MS, Schellhammer P, Sharifi R, Venner P, Patterson AL, Sarosdy M, Vogelzang N, Jones J, Kolvenbag G. Soloway MS, et al. Among authors: kolvenbag g. Eur Urol. 1996;29 Suppl 2:105-9. doi: 10.1159/000473848. Eur Urol. 1996. PMID: 8717471 Clinical Trial.
A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate cancer. Casodex Combination Study Group.
Schellhammer P, Sharifi R, Block N, Soloway M, Venner P, Patterson AL, Sarosdy M, Vogelzang N, Jones J, Kolvenbag G. Schellhammer P, et al. Among authors: kolvenbag g. Urology. 1995 May;45(5):745-52. doi: 10.1016/s0090-4295(99)80077-6. Urology. 1995. PMID: 7538237 Clinical Trial.
Maximal androgen blockade for patients with metastatic prostate cancer: outcome of a controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy. Casodex Combination Study Group.
Schellhammer P, Sharifi R, Block N, Soloway M, Venner P, Patterson AL, Sarosdy M, Vogelzang N, Jones J, Kolvenbag G. Schellhammer P, et al. Among authors: kolvenbag g. Urology. 1996 Jan;47(1A Suppl):54-60; discussion 80-4. doi: 10.1016/s0090-4295(96)80010-0. Urology. 1996. PMID: 8560679 Clinical Trial.
A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate carcinoma. Analysis of time to progression. CASODEX Combination Study Group.
Schellhammer PF, Sharifi R, Block NL, Soloway MS, Venner PM, Patterson AL, Sarosdy MF, Vogelzang NJ, Chen Y, Kolvenbag GJ. Schellhammer PF, et al. Among authors: kolvenbag gj. Cancer. 1996 Nov 15;78(10):2164-9. doi: 10.1002/(sici)1097-0142(19961115)78:10<2164::aid-cncr18>3.0.co;2-x. Cancer. 1996. PMID: 8918410 Clinical Trial.
Clinical benefits of bicalutamide compared with flutamide in combined androgen blockade for patients with advanced prostatic carcinoma: final report of a double-blind, randomized, multicenter trial. Casodex Combination Study Group.
Schellhammer PF, Sharifi R, Block NL, Soloway MS, Venner PM, Patterson AL, Sarosdy MF, Vogelzang NJ, Schellenger JJ, Kolvenbag GJ. Schellhammer PF, et al. Among authors: kolvenbag gj. Urology. 1997 Sep;50(3):330-6. doi: 10.1016/s0090-4295(97)00279-3. Urology. 1997. PMID: 9301693 Clinical Trial.
Comparison of goserelin and leuprolide in combined androgen blockade therapy.
Sarosdy MF, Schellhammer PF, Sharifi R, Block NL, Soloway MS, Venner PM, Patterson AL, Vogelzang NJ, Chodak GW, Klein EA, Schellenger JJ, Kolvenbag GJ. Sarosdy MF, et al. Among authors: kolvenbag gj. Urology. 1998 Jul;52(1):82-8. doi: 10.1016/s0090-4295(98)00145-9. Urology. 1998. PMID: 9671875 Clinical Trial.
Exploratory analysis on the effect of race on clinical outcome in patients with advanced prostate cancer receiving bicalutamide or flutamide, each in combination with LHRH analogues. The Casodex Combination Study Group.
McLeod DG, Schellhammer PF, Vogelzang NJ, Soloway MS, Sharifi R, Block NL, Venner PM, Patterson AL, Sarosdy MF, Kelley RP, Kolvenbag GJ. McLeod DG, et al. Among authors: kolvenbag gj. Prostate. 1999 Sep 1;40(4):218-24. doi: 10.1002/(sici)1097-0045(19990901)40:4<218::aid-pros2>3.0.co;2-6. Prostate. 1999. PMID: 10420149 Clinical Trial.
Serum PSA decline after Casodex withdrawal.
Schellhammer PF, Kolvenbag GJ. Schellhammer PF, et al. Among authors: kolvenbag gj. Urology. 1994 Nov;44(5):790-2. doi: 10.1016/s0090-4295(94)80234-3. Urology. 1994. PMID: 7526530 No abstract available.
32 results